@import url(http://finance.paidcontent.org/client/paidcontent/privatelabel.css);
February 11, 2012 at 05:11 AM EST
The Week in Review: Fosun Pharma Plans Large Hong Kong IPO
Shanghai Fosun Pharma’s on-again/off-again Hong Kong IPO is now scheduled to take place early this year, according to reports; Shanghai Pharma will buy Changzhou Kony Pharm to boost its portfolio of APIs for antivirals and cardiovascular drugs; Shanghai Pharma will also set up a Beijing headquarters for North China with $80 million of initial capital; Shanghai Biochip (ShanghaiBio) signed an MOU with GeneNews Limited to form a molecular diagnostics collaboration; Changchun BCHT Biotechnology obtained an exclusive license for an attenuated flu vaccine technology from BioDiem; Takeda Pharma established a new China division, Takeda Shanghai Development Center, which will run the company’s clinical development projects in Asia; and Nanjing Pharma’s declining fortunes are rumored to have made the company a takeover target. More details….. Stock Symbols: (SHA: 600196) (SHA: 601607; HK: 02607) (TO: 4502) (SHA: 600713) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here